Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Premarket analyst action - healthcare

Published 04/24/2018, 08:38 AM
Updated 04/24/2018, 08:38 AM
© Reuters.  Premarket analyst action - healthcare

© Reuters. Premarket analyst action - healthcare

  • Aeglea BioTherapeutics (NASDAQ:AGLE) initiated with Outperform rating and $37 (368% upside) price target at Evercore ISI. Shares up 5% premarket.
  • Alder Biopharmaceuticals (NASDAQ:ALDR) initiated with Neutral rating and $17 (25% upside) price target at Goldman Sachs (NYSE:GS).
  • Homology Medicines (NASDAQ:FIXX) initiated with Buy rating and $35 (76% upside) price target at BTIG Research.
  • Allscripts Healthcare Solutions (NASDAQ:MDRX) resumed with Overweight rating and $16 (31% upside) price target at JPMorgan (NYSE:JPM). Shares up 6% premarket.
  • Athenahealth (NASDAQ:ATHN) resumed with Neutral rating and $159 (11% upside) price target at JPMorgan.
  • Allergan (NYSE:AGN) resumed with Buy rating and $200 (25% upside) price target at Citigroup (NYSE:C). Shares up 1% premarket.
  • HealthEquity (NASDAQ:HQY) assumed with Overweight rating and $69 (5% upside) at JPMorgan.
  • BIO-key International (OTCQB:BKYI) resumed with Buy rating and $5.50 (163% upside) price target at Maxim Group.
  • Cardinal Health (NYSE:CAH) upgraded to Outperform at Leerink.
  • Prothena (NASDAQ:PRTA) downgraded to Neutral at Oppenheimer and BTIG Research after NEOD001 flop in Alzheimer's.
  • Henry Schein (NASDAQ:HSIC) downgraded to Neutral at Goldman Sachs. Shares down 1% premarket.
  • ResMed (NYSE:RMD) downgraded to Neutral with a $104 (6% upside) price target at UBS. Shares down 1% premarket.
  • Cotiviti Holdings (NYSE:COTV) downgraded to Neutral with a $37 (7% upside) price target at JPMorgan.
  • Quality Systems (NASDAQ:QSII) assumed at JPMorgan with Underweight rating and $15 (6% upside) price target at JPMorgan.
  • Now read: Cardinal Health: Keen Valuation And Dividend Growth


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.